retatrutide new england journal of medicine is generating a lot buzz in the medical weight loss world—and for good reason. As research continues, many experts believe it could represent the next generation of metabolic health treatments retatrutide triple agonist glp-1 gip

They are not fertility medications and do not replace hormonal treatments when those are needed

However, recent reports suggest no significant risk in humans

OTHERS Recent investigations have elucidated a multifaceted spectrum of adverse effects linked to GLP-1 RAs (Table 1), necessitating meticulous interpretation based on the various methodological designs employed, including RCTs and retrospective analyses

This process ensures the right patients receive the right medications at the right dose

This is one reason I counsel patients to think about GLP-1 medications as part of a broader strategy rather than a standalone solution